Mary Tagliaferri, M.D.

Dr. Tagliaferri is executive clinical fellow as well as SVP of Nektar, where she previously served as chief medical officer. She has been responsible for numerous clinical studies evaluating novel therapeutics in oncology. She currently serves on the board of Enzo Biochem.

  • March 2022

Added to: RayzeBio Inc. - San Diego, CA

RayeBio is a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets.